Annual FCF
-$75.86 M
-$13.14 M-20.96%
December 31, 2023
Summary
- As of February 7, 2025, ALT annual free cash flow is -$75.86 million, with the most recent change of -$13.14 million (-20.96%) on December 31, 2023.
- During the last 3 years, ALT annual FCF has fallen by -$41.21 million (-118.93%).
- ALT annual FCF is now -13785.19% below its all-time high of $554.30 thousand, reached on December 31, 2005.
Performance
ALT Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly FCF
-$27.12 M
-$9.01 M-49.76%
September 30, 2024
Summary
- As of February 7, 2025, ALT quarterly free cash flow is -$27.12 million, with the most recent change of -$9.01 million (-49.76%) on September 30, 2024.
- Over the past year, ALT quarterly FCF has dropped by -$10.59 million (-64.02%).
- ALT quarterly FCF is now -1130.16% below its all-time high of $2.63 million, reached on June 30, 2015.
Performance
ALT Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM FCF
-$78.12 M
-$6.63 M-9.28%
September 30, 2024
Summary
- As of February 7, 2025, ALT TTM free cash flow is -$78.12 million, with the most recent change of -$6.63 million (-9.28%) on September 30, 2024.
- Over the past year, ALT TTM FCF has dropped by -$2.26 million (-2.98%).
- ALT TTM FCF is now -11932.17% below its all-time high of $660.20 thousand, reached on June 30, 2006.
Performance
ALT TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
ALT Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -21.0% | -64.0% | -3.0% |
| 3 y3 years | -118.9% | -51.6% | +4.6% |
| 5 y5 years | -629.1% | -1013.0% | -711.1% |
ALT Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -21.0% | +16.2% | -100.3% | at low | -24.6% | +13.7% |
| 5 y | 5-year | -687.6% | +16.2% | -1252.9% | at low | -711.1% | +13.7% |
| alltime | all time | <-9999.0% | +16.2% | -1130.2% | at low | <-9999.0% | +13.7% |
Altimmune Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$27.12 M(+49.8%) | -$78.12 M(+9.3%) |
| Jun 2024 | - | -$18.11 M(+10.7%) | -$71.48 M(-1.7%) |
| Mar 2024 | - | -$16.36 M(-1.1%) | -$72.76 M(-4.1%) |
| Dec 2023 | -$75.86 M(+21.0%) | -$16.53 M(-19.3%) | -$75.86 M(-1.1%) |
| Sep 2023 | - | -$20.49 M(+5.7%) | -$76.67 M(+7.5%) |
| Jun 2023 | - | -$19.38 M(-0.4%) | -$71.29 M(+3.9%) |
| Mar 2023 | - | -$19.46 M(+12.2%) | -$68.64 M(+9.4%) |
| Dec 2022 | -$62.71 M(-30.7%) | -$17.34 M(+14.8%) | -$62.71 M(-7.1%) |
| Sep 2022 | - | -$15.11 M(-9.6%) | -$67.49 M(-4.0%) |
| Jun 2022 | - | -$16.72 M(+23.6%) | -$70.27 M(-12.4%) |
| Mar 2022 | - | -$13.54 M(-38.8%) | -$80.25 M(-11.4%) |
| Dec 2021 | -$90.55 M(+161.3%) | -$22.12 M(+23.6%) | -$90.55 M(+10.6%) |
| Sep 2021 | - | -$17.89 M(-33.0%) | -$81.86 M(+11.3%) |
| Jun 2021 | - | -$26.70 M(+12.0%) | -$73.55 M(+35.9%) |
| Mar 2021 | - | -$23.84 M(+77.6%) | -$54.10 M(+56.2%) |
| Dec 2020 | -$34.65 M(+259.8%) | -$13.43 M(+40.1%) | -$34.65 M(+49.2%) |
| Sep 2020 | - | -$9.58 M(+32.1%) | -$23.23 M(+44.5%) |
| Jun 2020 | - | -$7.25 M(+65.4%) | -$16.08 M(+35.1%) |
| Mar 2020 | - | -$4.38 M(+118.8%) | -$11.90 M(+23.5%) |
| Dec 2019 | -$9.63 M(-7.4%) | -$2.00 M(-17.7%) | -$9.63 M(-24.7%) |
| Sep 2019 | - | -$2.44 M(-20.7%) | -$12.79 M(+10.8%) |
| Jun 2019 | - | -$3.07 M(+45.2%) | -$11.54 M(+39.2%) |
| Mar 2019 | - | -$2.12 M(-59.0%) | -$8.30 M(-20.3%) |
| Dec 2018 | -$10.40 M(-48.9%) | -$5.16 M(+333.4%) | -$10.40 M(+3.3%) |
| Sep 2018 | - | -$1.19 M(-775.0%) | -$10.08 M(-23.5%) |
| Jun 2018 | - | $176.50 K(-104.2%) | -$13.17 M(-37.9%) |
| Mar 2018 | - | -$4.23 M(-12.6%) | -$21.21 M(+4.1%) |
| Dec 2017 | -$20.38 M(+210.0%) | -$4.83 M(+12.9%) | -$20.38 M(+19.3%) |
| Sep 2017 | - | -$4.28 M(-45.6%) | -$17.08 M(+15.3%) |
| Jun 2017 | - | -$7.86 M(+131.3%) | -$14.81 M(+71.8%) |
| Mar 2017 | - | -$3.40 M(+121.6%) | -$8.62 M(+31.1%) |
| Dec 2016 | -$6.57 M(+99.0%) | -$1.53 M(-23.8%) | -$6.57 M(-4.5%) |
| Sep 2016 | - | -$2.01 M(+20.4%) | -$6.89 M(+10.8%) |
| Jun 2016 | - | -$1.67 M(+23.3%) | -$6.21 M(+225.4%) |
| Mar 2016 | - | -$1.36 M(-26.6%) | -$1.91 M(-42.2%) |
| Dec 2015 | -$3.30 M | -$1.85 M(+38.0%) | -$3.30 M(-33.7%) |
| Sep 2015 | - | -$1.34 M(-150.9%) | -$4.98 M(-13.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2015 | - | $2.63 M(-195.8%) | -$5.78 M(-35.7%) |
| Mar 2015 | - | -$2.75 M(-22.0%) | -$8.98 M(+4.9%) |
| Dec 2014 | -$8.57 M(+18.1%) | -$3.52 M(+64.8%) | -$8.57 M(-24.2%) |
| Sep 2014 | - | -$2.14 M(+271.4%) | -$11.30 M(+14.7%) |
| Jun 2014 | - | -$575.50 K(-75.3%) | -$9.85 M(+0.4%) |
| Mar 2014 | - | -$2.33 M(-62.7%) | -$9.82 M(+35.4%) |
| Dec 2013 | -$7.25 M(+212.2%) | -$6.26 M(+805.8%) | -$7.25 M(+130.9%) |
| Sep 2013 | - | -$690.70 K(+27.8%) | -$3.14 M(+338.7%) |
| Jun 2013 | - | -$540.50 K(-330.1%) | -$716.10 K(-75.1%) |
| Mar 2013 | - | $234.90 K(-111.0%) | -$2.88 M(+24.0%) |
| Dec 2012 | -$2.32 M(-70.5%) | -$2.15 M(-223.7%) | -$2.32 M(+136.3%) |
| Sep 2012 | - | $1.73 M(-164.2%) | -$982.90 K(-84.6%) |
| Jun 2012 | - | -$2.70 M(-441.6%) | -$6.38 M(+27.5%) |
| Mar 2012 | - | $791.40 K(-198.3%) | -$5.00 M(-36.5%) |
| Dec 2011 | -$7.88 M(-48.3%) | -$805.10 K(-78.0%) | -$7.88 M(-43.1%) |
| Sep 2011 | - | -$3.66 M(+175.5%) | -$13.84 M(+18.0%) |
| Jun 2011 | - | -$1.33 M(-36.4%) | -$11.73 M(-7.4%) |
| Mar 2011 | - | -$2.09 M(-69.2%) | -$12.66 M(-16.9%) |
| Dec 2010 | -$15.24 M(-47.8%) | -$6.77 M(+336.4%) | -$15.24 M(+7.7%) |
| Sep 2010 | - | -$1.55 M(-31.4%) | -$14.14 M(-34.8%) |
| Jun 2010 | - | -$2.26 M(-51.5%) | -$21.71 M(-19.3%) |
| Mar 2010 | - | -$4.66 M(-17.8%) | -$26.91 M(-7.8%) |
| Dec 2009 | -$29.18 M(+112.8%) | -$5.67 M(-37.7%) | -$29.18 M(+6.6%) |
| Sep 2009 | - | -$9.11 M(+22.1%) | -$27.38 M(+15.7%) |
| Jun 2009 | - | -$7.46 M(+7.8%) | -$23.67 M(+55.2%) |
| Mar 2009 | - | -$6.92 M(+78.6%) | -$15.25 M(+11.3%) |
| Dec 2008 | -$13.71 M(-5.6%) | -$3.88 M(-28.2%) | -$13.71 M(+39.4%) |
| Sep 2008 | - | -$5.40 M(-667.5%) | -$9.83 M(+122.0%) |
| Jun 2008 | - | $952.00 K(-117.7%) | -$4.43 M(-17.7%) |
| Mar 2008 | - | -$5.38 M(+142.1%) | -$5.38 M(-68.3%) |
| Dec 2007 | -$14.52 M(+1.4%) | - | - |
| Mar 2007 | - | -$2.22 M(-57.2%) | -$16.95 M(+18.4%) |
| Dec 2006 | -$14.32 M(-2682.8%) | -$5.20 M(-46.9%) | -$14.32 M(+57.0%) |
| Sep 2006 | - | -$9.78 M(-4053.7%) | -$9.12 M(-1481.6%) |
| Jun 2006 | - | $247.40 K(-40.1%) | $660.20 K(+59.9%) |
| Mar 2006 | - | $412.80 K | $412.80 K |
| Dec 2005 | $554.30 K | - | - |
FAQ
- What is Altimmune annual free cash flow?
- What is the all time high annual FCF for Altimmune?
- What is Altimmune annual FCF year-on-year change?
- What is Altimmune quarterly free cash flow?
- What is the all time high quarterly FCF for Altimmune?
- What is Altimmune quarterly FCF year-on-year change?
- What is Altimmune TTM free cash flow?
- What is the all time high TTM FCF for Altimmune?
- What is Altimmune TTM FCF year-on-year change?
What is Altimmune annual free cash flow?
The current annual FCF of ALT is -$75.86 M
What is the all time high annual FCF for Altimmune?
Altimmune all-time high annual free cash flow is $554.30 K
What is Altimmune annual FCF year-on-year change?
Over the past year, ALT annual free cash flow has changed by -$13.14 M (-20.96%)
What is Altimmune quarterly free cash flow?
The current quarterly FCF of ALT is -$27.12 M
What is the all time high quarterly FCF for Altimmune?
Altimmune all-time high quarterly free cash flow is $2.63 M
What is Altimmune quarterly FCF year-on-year change?
Over the past year, ALT quarterly free cash flow has changed by -$10.59 M (-64.02%)
What is Altimmune TTM free cash flow?
The current TTM FCF of ALT is -$78.12 M
What is the all time high TTM FCF for Altimmune?
Altimmune all-time high TTM free cash flow is $660.20 K
What is Altimmune TTM FCF year-on-year change?
Over the past year, ALT TTM free cash flow has changed by -$2.26 M (-2.98%)